Dairy farmer income, working time, and antimicrobial use under different dry cow therapy protocols

Source Agritrop Cirad (https://agritrop.cirad.fr/612083/)

International audience

anglais. Mastitis is one of the most common diseases of dairy cattle. It has a high impact on-farm economy, farmers' working time, and antimicrobial usage (AMU). Selective dry cow therapy (SDCT) is an effective means of reducing AMU without negatively affecting udder health. The objective of our study was to evaluate the impact of SDCT implementation on farmer income, working time, and AMU, using a bioeconomic model. A stochastic dairy simulation model (DairyHealthSim) based on a weekly model was used to simulate herd dynamics, reproduction, milk production, culling decisions, health outcomes, and the management of health events. A specific module was developed for the simulation of quarter-level IMI acquisition and elimination during the lactation and dry-off periods, and 25 different farm settings were defined to represent herds with various udder health situations. We then defined 20 scenarios of SDCT by combining both the use of different thresholds of SCC and milk bacteriology for treatment allocation and the use of internal teat sealant (ITS). All SDCT protocols had little effect on farmer income, and we identified some protocols with a positive farm gross margin (up to Can$15.83/dried cow; at time of writing, Can$1 = US$0.72). We also found that adding an ITS to all cows led to greater economic gain. The application of SDCT had little effect on farmers' working time, except when milk bacteriology was used for decision making. Antimicrobial treatment to all cows above 200,000 cells/mL at last control, with the use of ITS on all cows, seems a good choice in most dairy farms. These findings could be used to convince farmers to adopt this strategy at dry-off.